Skrzypczak Marzena, Podralska Marta, Heinritz Wolfram, Froster Ursula G, Lipiński Daniel, Słomski Ryszard, Pławski Andrzej
Institute of Human Genetics, Polish Academy of Sciences, Poznań, Poland.
Hered Cancer Clin Pract. 2006 Jan 15;4(1):43-7. doi: 10.1186/1897-4287-4-1-43.
Familial Adenomatous Polyposis (FAP) is an inheritable predisposition for the occurrence of numerous polyps in the large intestine. In about 50% of all patients, the occurrence of the disease is conditioned by heterozygotic mutations of the APC gene. Screening for genetic factors in persons without mutations in the APC gene led to the identification of homozygotic mutations of the MYH gene as the cause of the appearance of the polyposis form which is characterized by recessive heritability and a milder course than in the case of the classic form of the disease. The authors examined 90 persons from the DNA bank of patients with FAP from the Institute of Human Genetics of the Polish Academy of Sciences in Poznań in whom no mutations in the APC gene were detected. Two of the most frequent mutations of the MYH gene (Y165C and G382D) were found to be heterozygous in 13% of patients and no other mutations in this gene coding sequence were observed. In the group with heterozygotic occurrence of the mutation in the MYH gene, the disease phenotype was not milder in comparison with the entire examined group and the mean age of the disease manifestation was even lower. This observation allows one to conclude that the employed methods of mutation screening were correct and, in the case of the examined group, the mutation ratio of the MYH gene does not precondition the occurrence of the disease, but it cannot be excluded that it may modify its phenotype. The obtained results indicate that the criteria applied during the process of FAP qualification are more rigorous than those applied in other countries.
家族性腺瘤性息肉病(FAP)是一种遗传性易患疾病,可导致大肠出现大量息肉。在所有患者中,约50%的疾病发生是由APC基因的杂合突变引起的。对APC基因无突变的人群进行遗传因素筛查,发现MYH基因的纯合突变是息肉病形式出现的原因,其特征为隐性遗传,病程比经典疾病形式更为温和。作者检查了来自波兹南波兰科学院人类遗传学研究所FAP患者DNA库的90人,这些人未检测到APC基因的突变。发现MYH基因最常见的两种突变(Y165C和G382D)在13%的患者中为杂合子,且未观察到该基因编码序列中的其他突变。在MYH基因杂合突变的组中,与整个检查组相比,疾病表型并不更温和,疾病表现的平均年龄甚至更低。这一观察结果使人们得出结论,所采用的突变筛查方法是正确的,对于检查组而言,MYH基因的突变率并非疾病发生的先决条件,但不能排除它可能改变疾病表型。所得结果表明,FAP资格认定过程中应用的标准比其他国家应用的标准更为严格。